PAM
IRWD icon

Paradigm Asset Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Paradigm Asset Management’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-3,701
Closed -$58.5K – 457
2017
Q2 		$58.5K Sell
3,701
-3,821
-51% -$55.5K 0.01% 502
2017
Q1 		$107K Buy
+7,522
New +$103K 0.02% 509
2015
Q3 		– Sell
-229,845
Closed -$2.32M – 836
2015
Q2 		$2.32M Hold
229,845
– – 0.26% 124
2015
Q1 		$3.08M Buy
229,845
+2,388
+1% +$31.3K 0.34% 93
2014
Q4 		$2.92M Buy
227,457
+11,582
+5% +$133K 0.38% 89
2014
Q3 		$2.34M Buy
+215,875
New +$2.47M 0.33% 100

Other funds holding IRWD

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Paradigm Asset Management's IRWD Position: Q3 2017 in Review

Paradigm Asset Management sold out of Ironwood Pharmaceuticals (IRWD) in Q3 2017, closing a stake of 3,701 shares — an estimated $58.5K sold.

Paradigm Asset Management first reported a position in IRWD in Q3 2014 and held it in 6 quarters. The position peaked at $3.08M in Q1 2015. 149 funds tracked by Wall St. Rank hold IRWD as of Q3 2017.

  • Paradigm Asset Management reported no remaining Ironwood Pharmaceuticals position as of Q3 2017 after selling out during the quarter.
  • Paradigm Asset Management sold 3,701 Ironwood Pharmaceuticals shares in Q3 2017, an estimated $58.5K.
  • Paradigm Asset Management first reported a position in Ironwood Pharmaceuticals in Q3 2014 and held it in 6 quarters.
  • Paradigm Asset Management's Ironwood Pharmaceuticals position peaked at $3.08M in Q1 2015.
  • 149 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q3 2017.

Based on Paradigm Asset Management's 13F filing for Q3 2017, filed 14 Nov 2017.